Access cutting-edge opioid use disorder treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.
Access opioid use disorder specialists in Wilmington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid use disorder treatment provided free
VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous (in the belly area) formulation of buprenorphine at a target dose of 300mg is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorphine formulation at a target dose of 16-32 mg (standard of care). This is an open-label, randomized, controlled trial including 952 Veterans with opioid use disorder (OUD) recruited over 7 years a
Sponsor: VA Office of Research and Development
Check if you qualify for this opioid use disorder clinical trial in Wilmington, DE
If you're searching for opioid use disorder treatment options in Wilmington, DE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.